Involvement of uric acid transporters in alteration of serum uric acid level by angiotensin II receptor blockers.
about
Extra-renal elimination of uric acid via intestinal efflux transporter BCRP/ABCG2Effect of hypouricaemic and hyperuricaemic drugs on the renal urate efflux transporter, multidrug resistance protein 4.Linkage of organic anion transporter-1 to metabolic pathways through integrated "omics"-driven network and functional analysis.Short- and long-term outcomes with renin-angiotensin-aldosterone inhibitors in renal transplant recipients: A meta-analysis of randomized controlled trials.Transporter-mediated drug-drug interactions.PharmGKB summary: uric acid-lowering drugs pathway, pharmacodynamics.In Vitro and In Vivo Interaction Studies Between Lesinurad, a Selective Urate Reabsorption Inhibitor, and Major Liver or Kidney Transporters.Renal Drug Transporters and Drug Interactions.Prediction of Altered Bile Acid Disposition Due to Inhibition of Multiple Transporters: An Integrated Approach Using Sandwich-Cultured Hepatocytes, Mechanistic Modeling, and Simulation.Organic anion transporter OAT1 is involved in renal handling of citrulline.Functional cooperation of URAT1 (SLC22A12) and URATv1 (SLC2A9) in renal reabsorption of urate.The management of hyperuricemia: back to the pathophysiology of uric acid.Transport properties of valsartan, sacubitril and its active metabolite (LBQ657) as determinants of disposition.Effects of telmisartan and pioglitazone on high fructose induced metabolic syndrome in rats.Uric acid stimulates proliferative pathways in vascular smooth muscle cells through the activation of p38 MAPK, p44/42 MAPK and PDGFRβ.Stronger Uricosuric Effects of the Novel Selective URAT1 Inhibitor UR-1102 Lowered Plasma Urate in Tufted Capuchin Monkeys to a Greater Extent than Benzbromarone.
P2860
Q28575931-F45C055B-C33E-4022-83F9-6161E3AAB8CEQ34596040-E7DD35CF-C81C-44E5-8197-6F79CDB95090Q35213248-0861F2D4-BED4-4959-874A-AA7BAC15427CQ36276748-18E787D1-266B-415C-B050-CD1C93FB3E92Q37905033-3055F949-BF3A-4437-96EE-667BAC5521DCQ38219092-6A83664E-8A91-4636-A492-71B2550E9AA7Q38788228-1EBA87D1-911E-4BFA-95D0-B211964A4CABQ39140289-35449491-0A61-49E9-B5F3-B81967820D4CQ39730975-A582D08E-3E82-4B4F-BF1D-3E646A8F751BQ39858796-B9102E97-2F6F-4D68-977F-0D97DF06D606Q48632787-078C712A-16ED-4BF8-8DC5-7DB020174CB4Q49793170-8BCB004A-3345-4C48-9D72-ACD765E61808Q51102882-00DD39E3-3BF2-4342-8B61-5A0DEDDF5ACBQ51283845-B3BF6AD9-72A5-4175-928D-D173BFE93614Q51649804-C5240C5B-884B-4CEE-952B-1A97F3B07AEBQ52883623-6E324866-6AAD-46AA-827C-F59F5A89CB84
P2860
Involvement of uric acid transporters in alteration of serum uric acid level by angiotensin II receptor blockers.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Involvement of uric acid trans ...... iotensin II receptor blockers.
@en
type
label
Involvement of uric acid trans ...... iotensin II receptor blockers.
@en
prefLabel
Involvement of uric acid trans ...... iotensin II receptor blockers.
@en
P2093
P1476
Involvement of uric acid trans ...... iotensin II receptor blockers.
@en
P2093
Hideaki Mamada
Hikaru Yabuuchi
Ikumi Tamai
Masanobu Sato
Takashi Iwanaga
Tomoji Maeda
Toshio Ogihara
P304
P356
10.1007/S11095-007-9401-6
P577
2007-08-03T00:00:00Z